Proteins Encoded by the Human T-Lymphotropic Virus Type III/ Lymphadenopathy Associated Virus (HTLV-III/LAV) Genes

No abstract is available for this paper.

• Publication year

  1986

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1007/978-1-4684-5242-6_27
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Biochemical heterogeneity of reverse transcriptase purified from the AIDS virus, HTLV‐III

  1986cited by this paper
• Recombinant polypeptide from the endonuclease region of the acquired immune deficiency syndrome retrovirus polymerase (pol) gene detects serum antibodies in most infected individuals

  1986cited by this paper
• Serological relationship between reverse transcriptases from human T-cell lymphotropic viruses defined by monoclonal antibodies. Evidence for two forms of reverse transcriptases in the AIDS-associated virus, HTLV-III/LAV.

  1986cited by this paper
• Three novel genes of human T-lymphotropic virus type III: immune reactivity of their products with sera from acquired immune deficiency syndrome patients.

  1986cited by this paper
• Characterization of highly immunogenic p66/p51 as the reverse transcriptase of HTLV-III/LAV.

  1986cited by this paper
• Location of the trans-activating region on the genome of human T-cell lymphotropic virus type III.

  1985cited by this paper
• Complete nucleotide sequence of the AIDS virus, HTLV-III

  1985cited by this paper
• Apparent transmission of human T-cell leukemia virus type III to a heterosexual woman with the acquired immunodeficiency syndrome.

  1985cited by this paper
• Major glycoprotein antigens that induce antibodies in AIDS patients are encoded by HTLV-III.

  1985cited by this paper
• Trans-activator gene of human T-lymphotropic virus type III (HTLV-III).

  1985cited by this paper
• Seroepidemiology of human T-lymphotropic virus type III among homosexual men with the acquired immunodeficiency syndrome or generalized lymphadenopathy and among asymptomatic controls in Boston.

  1985cited by this paper
• Characterization of gp41 as the transmembrane protein coded by the HTLV-III/LAV envelope gene.

  1985cited by this paper
• Infection with HTLV-III/LAV and transfusion-associated acquired immunodeficiency syndrome. Serologic evidence of an association.

  1985cited by this paper
• Immunological properties of HTLV-III antigens recognized by sera of patients with AIDS and AIDS-related complex and of asymptomatic carriers of HTLV-III infection.

  1985cited by this paper
• Immunological properties of the Gag protein p24 of the acquired immunodeficiency syndrome retrovirus (human T-cell leukemia virus type III).

  1985cited by this paper
• Trans activation of the bovine leukemia virus long terminal repeat in BLV-infected cells.

  1985cited by this paper
• Isolation of infectious human T-cell leukemia/lymphotropic virus type III (HTLV-III) from patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related complex (ARC) and from healthy carriers: a study of risk groups and tissue sources.

  1985cited by this paper
• Monoclonal antibodies specific for p24, the major core protein of human T-cell leukemia virus type III.

  1985cited by this paper
• Trans-acting transcriptional activation of the long terminal repeat of human T lymphotropic viruses in infected cells.

  1984cited by this paper
• Aetiology of AIDS—antibodies to human T-cell leukaemia virus (type III) in haemophiliacs

  1984cited by this paper
• Antibodies reactive with human T-lymphotropic retroviruses (HTLV-III) in the serum of patients with AIDS.

  1984cited by this paper
• Seroepidemiological studies of human T-lymphotropic retrovirus type III in acquired immunodeficiency syndrome.

  1984cited by this paper
• Immunological characterization of the low molecular weight gag gene proteins p19 and p15 of human T-cell leukemia-lymphoma virus (HTLV) and demonstration of human natural antibodies to them.

  1984cited by this paper
• Frequent detection and isolation of cytopathic retroviruses (HTLV-III) from patients with AIDS and at risk for AIDS.

  1984cited by this paper
• Detection, isolation, and continuous production of cytopathic retroviruses (HTLV-III) from patients with AIDS and pre-AIDS.

  1984cited by this paper
• Virologic studies in a case of transfusion-associated AIDS.

  1984cited by this paper
• Antibodies to the core protein of lymphadenopathy-associated virus (LAV) in patients with AIDS.

  1984cited by this paper
• In vivo modification of retroviral gag gene-encoded polyproteins by myristic acid

  1983cited by this paper
• Isolation of a T-lymphotropic retrovirus from a patient at risk for acquired immune deficiency syndrome (AIDS).

  1983cited by this paper
• Human T-cell leukemia-lymphoma virus (HTLV).

  1983cited by this paper
• Assembly of type C oncornaviruses: a model.

  1978cited by this paper
• Purification and characterization of the DNA polymerase and RNase H activities in Moloney murine sarcoma-leukemia virus

  1975cited by this paper
• A single subunit from avian myeloblastosis virus with both RNA-directed DNA polymerase and ribonuclease H activity.

  1973cited by this paper

• U.S. government information policy and the aids epidemic

  1989cites this paper